Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Nadunolimab in Combination With Gemcitabine Plus Carboplatin in Patients With Advanced Triple Negative Breast Cancer.

Cantargia AB · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
triplenegativebreastcancer
triple negative breast cancer, unresectable locally advanced, metastatic triple negative breast cancer, nadunolimab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 900025
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.